<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Axonal injury following <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> has attracted less attention than damage in grey matter </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is becoming increasingly recognised that axons are highly vulnerable to focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> [D </plain></SENT>
<SENT sid="2" pm="."><plain>Dewar, D.A </plain></SENT>
<SENT sid="3" pm="."><plain>Dawson, Changes of cytoskeletal protein immunostaining in myelinated fibre tracts after focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in the rat, Acta </plain></SENT>
<SENT sid="4" pm="."><plain>Neuropathol., 93 (1997) 71-77] [2]; [L </plain></SENT>
<SENT sid="5" pm="."><plain>Pantoni, J.H </plain></SENT>
<SENT sid="6" pm="."><plain>Garcia, J.A </plain></SENT>
<SENT sid="7" pm="."><plain>Gutierrez, Cerebral white matter is highly vulnerable to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:hpo ids='HP_0001297'>Stroke</z:hpo>, 27 (1996) 1641-1647] [10]; [P </plain></SENT>
<SENT sid="8" pm="."><plain>S </plain></SENT>
<SENT sid="9" pm="."><plain>Yam, T </plain></SENT>
<SENT sid="10" pm="."><plain>Takasago, D </plain></SENT>
<SENT sid="11" pm="."><plain>Dewar, D.I </plain></SENT>
<SENT sid="12" pm="."><plain>Graham, J </plain></SENT>
<SENT sid="13" pm="."><plain>McCulloch, Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion, Brain Res., 760 (1997) 150-157] [15] </plain></SENT>
<SENT sid="14" pm="."><plain>Since white matter does not contain neuronal cell bodies or synapses it is likely that the mechanisms of injury and strategies for its protection are different from those in grey matter </plain></SENT>
<SENT sid="15" pm="."><plain>In order that the effect of therapeutic intervention on the protection of axons can be assessed, a method by which axonal injury can be mapped and quantified is required </plain></SENT>
<SENT sid="16" pm="."><plain>For this purpose, we investigated immunocytochemical methods using amyloid precursor protein (APP) following permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the rat </plain></SENT>
<SENT sid="17" pm="."><plain>APP is transported by fast anterograde axonal transport [E.H </plain></SENT>
<SENT sid="18" pm="."><plain>Koo, S.S </plain></SENT>
<SENT sid="19" pm="."><plain>Sisodia, D.R </plain></SENT>
<SENT sid="20" pm="."><plain>Archer, L.J </plain></SENT>
<SENT sid="21" pm="."><plain>Martin, A </plain></SENT>
<SENT sid="22" pm="."><plain>Weidemann, K </plain></SENT>
<SENT sid="23" pm="."><plain>Beyreuther, P </plain></SENT>
<SENT sid="24" pm="."><plain>Fischer, C.L </plain></SENT>
<SENT sid="25" pm="."><plain>Masters, D.L </plain></SENT>
<SENT sid="26" pm="."><plain>Price, Precursor of amyloid protein in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> undergoes fast anterograde axonal transport, Proc </plain></SENT>
<SENT sid="27" pm="."><plain>Natl </plain></SENT>
<SENT sid="28" pm="."><plain>Acad </plain></SENT>
<SENT sid="29" pm="."><plain>Sci </plain></SENT>
<SENT sid="30" pm="."><plain>U.S.A </plain></SENT>
<SENT sid="31" pm="."><plain>87 (1990) 1561-1565] [7] and has been shown to accumulate following a variety of insults to axons, indicative of dysfunction of axonal transport [R.N </plain></SENT>
<SENT sid="32" pm="."><plain>Kalaria, S.U </plain></SENT>
<SENT sid="33" pm="."><plain>Bhatti, E.A </plain></SENT>
<SENT sid="34" pm="."><plain>Palatinsky, D.H </plain></SENT>
<SENT sid="35" pm="."><plain>Pennington, E.R </plain></SENT>
<SENT sid="36" pm="."><plain>Shelton, H.W </plain></SENT>
<SENT sid="37" pm="."><plain>Chan, G </plain></SENT>
<SENT sid="38" pm="."><plain>Perry, W.D </plain></SENT>
<SENT sid="39" pm="."><plain>Lust, Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain, Neuroreport, 4 (1993) 211-214] [4]; [T </plain></SENT>
<SENT sid="40" pm="."><plain>Kawarabayashi, M </plain></SENT>
<SENT sid="41" pm="."><plain>Shoji, Y </plain></SENT>
<SENT sid="42" pm="."><plain>Harigaya, H </plain></SENT>
<SENT sid="43" pm="."><plain>Yamaguchi, S </plain></SENT>
<SENT sid="44" pm="."><plain>Hirai, Expression of APP in the early stage of brain damage, Brain Res., 563 (1991) 334-338] [5]; [N </plain></SENT>
<SENT sid="45" pm="."><plain>Otsuka, M </plain></SENT>
<SENT sid="46" pm="."><plain>Tomonaga, K </plain></SENT>
<SENT sid="47" pm="."><plain>Ikeda, Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury, Brain Res., 568 (1991) 335-338] [9]; [K </plain></SENT>
<SENT sid="48" pm="."><plain>Shigematsu, P </plain></SENT>
<SENT sid="49" pm="."><plain>L </plain></SENT>
<SENT sid="50" pm="."><plain>McGeer, Accumulation of amyloid precursor protein in neurons after intraventricular injection of <z:chebi fb="0" ids="23359">colchicine</z:chebi>, Am </plain></SENT>
<SENT sid="51" pm="."><plain>J </plain></SENT>
<SENT sid="52" pm="."><plain>Pathol., 140 (1992) 787-794] [12] </plain></SENT>
<SENT sid="53" pm="."><plain>We have been able to map the topographical relationship between APP accumulation and region of infarction using immunocytochemistry and image analysis techniques </plain></SENT>
<SENT sid="54" pm="."><plain>Additionally, using a semi-quantitative scoring system, we have demonstrated that there is a relationship between the amount of APP accumulation and the volume of infarction following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="55" pm="."><plain>These methods will be useful in the future for the assessment of therapeutic interventions on the protection of axons following ischaemic injury </plain></SENT>
</text></document>